Xpert MTB/RIF in alveolar lavage fluid can not only detect RIF resistance but also distinguish pulmonary TB from NTM pulmonary disease in patients with positive acid-fast smears.

Xpert® MTB/RIF is a new test that quickly detects TB and resistance to rifampicin, one of the major drugs for treating the disease. Xpert® MTB/RIF is automated and can detect TB bacteria at low ...

The Xpert MTB/RIF test correctly identified 79.4% and 96.5% of children with and without culture confirmed pulmonary tuberculosis respectively. Using the Fagan normogram, ...

The Xpert MTB/RIF test is a nucleic acid amplification test that can test specifically for the mycobacterial DNA that causes TB. The test can detect TB even when the smear test appears negative.

Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: A systematic review and meta-analysis Date: March 24, 2015 Source: The Lancet ...

The development of the Xpert MTB/RIF assay has been the most important breakthrough for the diagnosis of tuberculosis in decades.This molecular-based test provides a rapid and sensitive method for ...

Point-of-care Xpert MTB/RIF tuberculosis testing is associated with more patients getting same-day diagnosis and having same-day treatment initiation but does not result in improved tuberculosis ...

The overall positivity in these 9 projects was similar to yields from the South Africa's rollout of Xpert MTB/RIF (15%). Among all MTB-positive results, 2.3% (163) were RIF indeterminate.

Xpert MTB/RIF further reduced the time to treatment initiation to a median of seven days, with more than 90% of people living with HIV who had rifampicin-resistant TB starting treatment. More than ...